MA49771A - Induction d'une immunité protectrice contre des antigènes - Google Patents

Induction d'une immunité protectrice contre des antigènes

Info

Publication number
MA49771A
MA49771A MA049771A MA49771A MA49771A MA 49771 A MA49771 A MA 49771A MA 049771 A MA049771 A MA 049771A MA 49771 A MA49771 A MA 49771A MA 49771 A MA49771 A MA 49771A
Authority
MA
Morocco
Prior art keywords
induction
immunity against
protective immunity
against antigens
antigens
Prior art date
Application number
MA049771A
Other languages
English (en)
Inventor
Roy Curtiss Iii
Shifeng Wang
Original Assignee
Univ Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida filed Critical Univ Florida
Publication of MA49771A publication Critical patent/MA49771A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/80—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
MA049771A 2017-08-04 2018-08-03 Induction d'une immunité protectrice contre des antigènes MA49771A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762541293P 2017-08-04 2017-08-04

Publications (1)

Publication Number Publication Date
MA49771A true MA49771A (fr) 2020-06-10

Family

ID=65233106

Family Applications (1)

Application Number Title Priority Date Filing Date
MA049771A MA49771A (fr) 2017-08-04 2018-08-03 Induction d'une immunité protectrice contre des antigènes

Country Status (6)

Country Link
US (1) US11596677B2 (fr)
EP (1) EP3661547A4 (fr)
CN (1) CN111182920B (fr)
BR (1) BR112020002374A2 (fr)
MA (1) MA49771A (fr)
WO (1) WO2019028396A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112019015140A2 (pt) 2017-01-23 2020-04-14 Univ Florida indução de imunidade protetora contra antígenos
US20240024380A1 (en) * 2020-12-23 2024-01-25 Chan Zuckerberg Biohub, Inc. Bacteria-engineered to elicit antigen-specific t cells

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY149604A (en) * 2005-04-18 2013-09-13 Schering Plough Ltd C.perfringens alpha toxoid vaccine
CA2685533C (fr) * 2007-06-22 2019-07-02 University Of Guelph Vaccin contre <i>clostridium perfringens</i>
WO2009046449A1 (fr) 2007-10-05 2009-04-09 The Arizona Board Of Regents For And On Behalf Of Arizona State University Bactéries recombinantes capables de susciter une réponse immunitaire contre des agents pathogènes entériques
WO2010045620A1 (fr) * 2008-10-17 2010-04-22 The Arizona Board Of Regents For And On Behalf Of Arizona State University Bactérie recombinante pouvant éliciter une réponse immunitaire contre le streptococcus pneumoniae
WO2011150421A2 (fr) 2010-05-28 2011-12-01 The Arizona Board Of Regents For And On Behalf Of Arizona State University Bactérie recombinante permettant de diminuer la croissance tumorale
US9198950B2 (en) * 2010-11-24 2015-12-01 Arizona Board Of Regents On Behalf Of Arizona State University Recombinant bacterium comprising a toxin/antitoxin system
EP2834356A4 (fr) * 2012-04-02 2015-09-02 Univ Arizona Bactérie recombinante pour induire une réponse immunitaire cellulaire
CA2893265A1 (fr) * 2012-11-30 2014-06-05 Universite D'auvergne Clermont 1 Utilisation de microorganismes pour reduire le niveau de trimethylamine dans une cavite du corps humain, en particulier pour le traitement de trimethylaminurie ou de vaginose bacterienne et la prevention de maladies cardiovasculaires
WO2015118541A1 (fr) 2014-02-05 2015-08-13 Gavish-Galilee Bio Applications Ltd Système génétique pour générer des bactéries inactivées ou atténuées de manière conditionnelle
WO2018018041A1 (fr) 2016-07-22 2018-01-25 University Of Florida Research Foundation, Incorporated Conception d'un vaccin anti-zikv qui n'a pas de réaction croisées avec la dengue.
BR112019015140A2 (pt) 2017-01-23 2020-04-14 Univ Florida indução de imunidade protetora contra antígenos

Also Published As

Publication number Publication date
EP3661547A1 (fr) 2020-06-10
WO2019028396A1 (fr) 2019-02-07
BR112020002374A2 (pt) 2020-09-08
EP3661547A4 (fr) 2021-06-09
US20200368339A1 (en) 2020-11-26
CN111182920A (zh) 2020-05-19
US11596677B2 (en) 2023-03-07
WO2019028396A8 (fr) 2020-02-13
CN111182920B (zh) 2023-09-12

Similar Documents

Publication Publication Date Title
MA47317A (fr) Induction d&#39;immunité protectrice contre des antigènes
MA49715A (fr) Oligomères et conjugués d&#39;oligomères
EP3209299A4 (fr) Inhibiteurs à petites molécules ciblant le récepteur du domaine discoïdine 1 et ses utilisations
MA43378A (fr) Compositions et méthodes pour la reduction de la réponse immunitaire contre récepteurs d&#39;antigène chimériques
DK3410822T3 (da) Elektromagnetisk induktionsopvarmer
BE1022355A1 (fr) Nouvelles méthodes d&#39;induction d&#39;une réponse immunitaire
MA49771A (fr) Induction d&#39;une immunité protectrice contre des antigènes
ITUB20153017A1 (it) Dispositivo per l&#39;avvolgimento di prodotti
IL262111A (en) Monovalent inhibitors of hutnfr1 interaction
GB2529487B (en) Protective long outerwear/bib
DK3535461T3 (da) Sprængningsbeskyttelsesvæg
FR3023385B1 (fr) Charniere d&#39;une monture de lunettes
ES1109830Y (es) &#34; senalador de prendas&#34;
MA38618A (fr) Protection d&#39;isolation contre les chocs de composants sensibles
GB2578588B (en) Enhancing the visibility of garments
GB201803843D0 (en) Improved protective garment
GB201610297D0 (en) &#39;Free heat&#39;
ES1157036Y (es) Percha protectora
DE112017007811A5 (de) Induktionsheizgerät
GB201714033D0 (en) Protective garment
FR3057727B1 (fr) Compression optimisee d&#39;entete ip-v6
IT201700081473A1 (it) Prevenzione mareggiate
IT201700090331A1 (it) &#34;lopemide&#34;
IT201700071679A1 (it) Remembebe&#39;
HUE056857T2 (hu) Immunitásindukáló